Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage: Commentary

Awad I.A.Dorsch N.W.C.YONG-KWANG TU2020-03-122020-03-1220040470-8105https://www.scopus.com/inward/record.uri?eid=2-s2.0-10044261776&partnerID=40&md5=7ae12e63b7d1f3a5bf9a21a56a19d1c2https://scholars.lib.ntu.edu.tw/handle/123456789/476006[SDGs]SDG3alteplase; calcium channel blocking agent; placebo; aneurysm clip; aneurysm surgery; animal experiment; blood clot; blood clot lysis; brain artery aneurysm; brain hematoma; brain hemorrhage; brain infection; brain ischemia; brain vasospasm; brain ventricular drainage; cerebrospinal fluid drainage; cisterna magna; cisternal catheter; clinical protocol; clinical trial; cohort analysis; computer assisted tomography; continuous cisternal drainage; craniotomy; disability; disease severity; Doppler echography; fatality; fisher grade; human; hydration; incidence; note; operation duration; outcomes research; postoperative care; postoperative complication; prevalence; primate; prospective study; scoring system; subarachnoid clot; surgical techniquePrevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage: Commentarynote2-s2.0-10044261776